REG - Tate & Lyle PLC - Directorate Change

Tate & LyleAnnouncement

24/03/2022 11:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220324:nRSX8358Fa&default-theme=true

RNS Number : 8358F  Tate & Lyle PLC  24 March 2022

24 March 2022

 

Tate & Lyle PLC

 

 

BOARD CHANGES

 

Tate & Lyle PLC (the "Company") announces that Dr Isabelle Esser will join
the Board as a non-executive director and as a member of the Remuneration and
Nominations Committees on 1 June 2022.

 

Isabelle has over thirty years' experience in global consumer food and
ingredient companies. In more than twenty-five years with Unilever PLC, she
held a range of innovation and transformation roles, finally as EVP, R&D
Foods Transformation, Global Foods and Refreshment.  After leaving Unilever
in 2019, Isabelle became the Chief Human Resources Officer at Barry Callebaut
AG, the Swiss-based global chocolate and cocoa products manufacturer.  In
April 2022, Isabelle will take up the role of Chief Research, Innovation and
Food Quality Safety Officer at Paris-based Danone SA, a global consumer food
and beverage manufacturer.

 

Dr Gerry Murphy, Chair of Tate & Lyle, said: "I am delighted that Isabelle
has agreed to join the Board. Her scientific expertise and extensive
technology leadership experience in our markets will be of significant benefit
to the Board."

 

There are no further disclosures to be made in connection with Dr Esser's
appointment pursuant to paragraph 9.6.13 of the Financial Conduct Authority's
Listing Rules.

 

 

END

 

 

For more information contact:

 

For Tate & Lyle PLC

 

Investors and analysts

Christopher Marsh, VP Investor Relations

Tel: Mobile: +44 (0) 7796 192 688

 

Media

Nick Hasell, FTI Consulting

Tel: Mobile: +44 (0) 7825 523 383

 

Information on Tate & Lyle

 

Tate & Lyle is a leading global provider of food and beverage ingredients
and solutions. Supported by our 160-year history of ingredient innovation, we
partner with customers to provide consumers with healthier and tastier choices
when they eat and drink. We are proud that millions of people around the world
consume products containing our ingredients every day.

 

Through our expertise in sweetening, mouthfeel and fibre fortification, our
Food & Beverage Solutions business develops solutions which reduce sugar,
calories and fat, add fibre, and provide texture and stability in categories
including beverages, dairy, bakery, soups, sauces and dressings.

 

Tate & Lyle's purpose is Improving Lives for Generations and through our
purpose we believe we can successfully grow our business and have a positive
impact on society. We live our purpose in three ways, by supporting healthy
living, building thriving communities and caring for our planet.

 

Tate & Lyle is listed on the London Stock Exchange under the symbol
TATE.L. American Depositary Receipts trade under TATYY. For more information,
please visit http://www.tateandlyle.com or follow Tate & Lyle on Twitter
or LinkedIn.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOASEWEEDEESEDD